Author(s): Tapan M. Kadia, MD1; Patrick K. Reville, MPH, MD2; Xuemei Wang, MS3; Caitlin R. Rausch, PharmD4; Gautam Borthakur, MD1; Naveen Pemmaraju, MD1; Naval G. Daver, MD1; Courtney D. DiNardo, MD, MSCE1; Koji Sasaki, MD, PhD1; Ghayas C. Issa, MD1; Maro Ohanian, MD1; Guillermo Montalban-Bravo, MD1; Nicholas J. Short, MD1; Nitin Jain, MD1; Alessandra Ferrajoli, MD1; Kapil N. Bhalla, MD1; Elias Jabbour, MD1; Koichi Takahashi, MD, PhD1; Rashmi Malla, BSN1; Kelly Quagliato, BS1; Rashmi Kanagal-Shamanna, MD5; Uday R. Popat, MD6; Michael Andreeff, MD, PhD1; Guillermo Garcia-Manero, MD1; Marina Y. Konopleva, MD, PhD1; Farhad Ravandi, MD1; and Hagop M. Kantarjian, MD1
Author Affiliations
1Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;
2Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX;
4Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX;
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX